Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WATSON LABS INC

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 46
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

NOVARTIS

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 40
  • 0 comments

FDA approve FINGOLIMOD HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 42
  • 0 comments

FDA approve FLUVOXAMINE MALEATE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 40
  • 0 comments

FDA approve TALQUETAMAB-TGVS

Comment Full text

TEVA

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 47
  • 0 comments

FDA approve FLUVOXAMINE MALEATE

Comment Full text

GRAVITI PHARMS

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 44
  • 0 comments

FDA approve CHLORZOXAZONE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 49
  • 0 comments

FDA approve TECLISTAMAB-CQYV

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 46
  • 0 comments

FDA approve ACETAZOLAMIDE

Comment Full text

GENENTECH INC

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 47
  • 0 comments

FDA approve PRALSETINIB

Comment Full text

NOSTRUM PHARMS LLC

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 49
  • 0 comments

FDA approve THEOPHYLLINE

Comment Full text
  • Previous
  • 719
  • 720
  • 721
  • 722
  • 723
  • Next

Search

News categories

  • Technical Exchange News(14740)
  • Event(6229)
  • SEC News(396208)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(241601)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin